Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry.

Clemente R, de Parseval A, Perez M, de la Torre JC.

J Virol. 2009 Mar;83(6):2655-62. doi: 10.1128/JVI.02206-08. Epub 2009 Jan 7.

2.

Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Sundstrom M, White RL, de Parseval A, Sastry KJ, Morris G, Grant CK, Elder JH.

J Virol. 2008 Sep;82(18):9134-42. doi: 10.1128/JVI.00394-08. Epub 2008 Jul 2.

3.

Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat.

de Roz├Čeres S, Thompson J, Sundstrom M, Gruber J, Stump DS, de Parseval AP, VandeWoude S, Elder JH.

J Virol. 2008 Aug;82(16):7953-63. doi: 10.1128/JVI.00337-08. Epub 2008 Jun 11.

4.

Molecular mechanisms of FIV infection.

Elder JH, Sundstrom M, de Rozieres S, de Parseval A, Grant CK, Lin YC.

Vet Immunol Immunopathol. 2008 May 15;123(1-2):3-13. doi: 10.1016/j.vetimm.2008.01.007. Epub 2008 Jan 19. Review.

5.

Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains.

Khurana S, Krementsov DN, de Parseval A, Elder JH, Foti M, Thali M.

J Virol. 2007 Nov;81(22):12630-40. Epub 2007 Sep 12.

6.
7.

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.

Binley JM, Ngo-Abdalla S, Moore P, Bobardt M, Chatterji U, Gallay P, Burton DR, Wilson IA, Elder JH, de Parseval A.

Retrovirology. 2006 Jul 3;3:39. Erratum in: Retrovirology. 2007;4:23.

9.

A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.

de Parseval A, Bobardt MD, Chatterji A, Chatterji U, Elder JH, David G, Zolla-Pazner S, Farzan M, Lee TH, Gallay PA.

J Biol Chem. 2005 Nov 25;280(47):39493-504. Epub 2005 Sep 12.

10.

Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus.

de Parseval A, Chatterji U, Morris G, Sun P, Olson AJ, Elder JH.

Nat Struct Mol Biol. 2005 Jan;12(1):60-6. Epub 2004 Dec 12.

PMID:
15592478
11.

Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor.

de Parseval A, Chatterji U, Sun P, Elder JH.

Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13044-9. Epub 2004 Aug 23.

12.
13.

Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN.

de Parseval A, Su SV, Elder JH, Lee B.

J Virol. 2004 Mar;78(5):2597-600.

15.

Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.

Chatterji U, de Parseval A, Elder JH.

J Virol. 2002 Oct;76(19):9624-34.

18.

FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation.

Lerner DL, Grant CK, de Parseval A, Elder JH.

Vet Immunol Immunopathol. 1998 Oct 23;65(2-4):277-97.

PMID:
9839880
20.

Influence of ORF2 on host cell tropism of feline immunodeficiency virus.

Waters AK, De Parseval AP, Lerner DL, Neil JC, Thompson FJ, Elder JH.

Virology. 1996 Jan 1;215(1):10-6.

21.

The generation of monoclonal antibodies recognising novel epitopes by immunisation with solid matrix antigen-antibody complexes reveals a polymorphic determinant on feline CD4.

Willett BJ, de Parseval A, Peri E, Rocchi M, Hosie MJ, Randall R, Klatzmann D, Neil JC, Jarrett O.

J Immunol Methods. 1994 Dec 2;176(2):213-20.

PMID:
7527069
22.

Unusual amino acid sequence of the second Ig-like domain of the feline CD4 protein.

Dumont-Drieux AM, De Parseval A, Heiber M, Salmon P, Pancino G, Sonigo P, Klatzmann D.

AIDS Res Hum Retroviruses. 1992 Sep;8(9):1581-91.

PMID:
1457204

Supplemental Content

Loading ...
Support Center